Latest Us Market News

Vitrafy Life Sciences reported an 80% revenue surge and halved its net loss, buoyed by US military validation and major blood network partnerships. A $32 million capital raise fuels its US commercial expansion and manufacturing scale-up.

Reckon Limited maintained steady revenue and EBITDA in constant currency during the first half of FY26, while NPAT rose 6%, driven by strong growth in its cloud products Reckon One and Billing Workflows alongside strategic AI investments.

Ava Risk Group has appointed Bryant Henson as CEO to spearhead its next growth phase, with a sharp focus on expanding its footprint in the United States and strengthening commercial execution worldwide.

Etherstack reports a 40% jump in first-half revenue to US$8.5 million, driven by strong trading momentum despite non-recurring expansion expenses. The company projects FY26 revenue between US$17.2 million and US$18.9 million amid ongoing growth initiatives.

Boresight Ltd (ASX: BST) marked its ASX debut in June with a successful $8 million IPO, reporting a 55% revenue increase in FY26 and securing a major US manufacturing expansion to meet rising defence drone demand.

4DMedical has secured a pivotal three-year contract with SimonMed Imaging to deploy its CT:VQ™ lung imaging technology across over 170 US outpatient centres, while FY26 revenue rose 23% to $7.2 million on record scan volumes and global expansion.

Eden Innovations reported strong EdenCrete® trial results in India and North America, strategic hires for EdenShield® in defence markets, and completed a $4.05 million placement, ending the quarter debt-free with $5.2 million cash.

Tissue Repair advances its US Phase III chronic wound trial with 100 patients randomised and targets October FDA 510(k) submission. The company reports a robust cash position bolstered by R&D refunds and has cut manufacturing scale-up costs.

Janus Electric navigated a transitional Q4 FY26 by settling legacy debts, raising $12 million, and growing its North American order book to 112 truck conversions, positioning itself for commercial scale-up.

Viking Mines has secured full permitting and contractor engagement for its maiden 63-hole drilling campaign at the Linka Tungsten Project in Nevada, alongside metallurgical testwork exceeding recovery targets and a strategic divestment of its First Hit Gold Project.

OncoSil Medical reported a 53% increase in unit sales and advanced key regulatory approvals, including FDA final review and TGA listing, positioning it for growth in pancreatic cancer treatment.

BCAL Diagnostics has strengthened its leadership, advanced breast cancer detection tests, and secured key funding and strategic investments to underpin its FY2027 growth plans.